Financial Daily from THE HINDU group of publications
Friday, Feb 03, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Alliances & Joint Ventures


Dr Reddy's ties up with UK's Argenta Discovery

Our Bureau

Hyderabad , Feb. 2

DR Reddy's Laboratories Ltd has announced that it has entered into an agreement with the UK-based privately held drug discovery and development company - Argenta Discovery Ltd - for the joint development and commercialisation of a novel approach to the treatment of chronic obstructive pulmonary disease (COPD).

In a press release here, Dr Reddy's said, under the terms of the agreement, both the companies would collaborate to identify clinical candidates from a certain class of Dr Reddy's' compounds for use as potential treatments for COPD.

Both the parties would jointly develop the selected candidates from the pre-clinical stage up to Phase II-a (proof-of-concept). On successful completion of a Phase II-a trial, the companies would either licence-out the candidate for further development and commercialisation to a larger pharmaceutical company or continue the further co-development and commercialisation themselves.

Both Dr Reddy's and Argenta have agreed to fund the joint collaboration up to proof-of-concept. However, Dr Reddy's did not disclose the financial terms of the agreement.

Commenting on the co-development deal, the Dr Reddy's Chief Executive Officer, Mr G.V. Prasad, said, "We are excited about the R&D collaboration with Argenta as it provides us with an opportunity to leverage our drug discovery capabilities to target unmet medical needs in the respiratory therapeutic area. Argenta brings the significant respiratory drug development expertise required to pursue a novel approach for the treatment of COPD, asthma and cystic fibrosis,"

Dr Chris Ashton, Chief Executive Officer of Argenta Discovery, said,

"We are delighted to be working with Dr Reddy's, which is establishing a growing reputation within the global pharmaceutical industry. We are proud that Argenta's expertise and experience in drug development and respiratory disease has been recognised by Dr Reddy's and we look forward to a long and fruitful collaboration."

More Stories on : Alliances & Joint Ventures

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Lanco bags 3 hydel projects in Uttaranchal


FCI OEN open offer to begin on February 15
Ministry favours 1/3 board representation for independent directors
Arcelor bid: Mittal Steel not perturbed by possible counter-offer
IOC shareholders okay lube manufacturing arm merger
Kia Motors likely to set up plant in India
Riddhi Siddhi completes capacity expansion — Bags Rs 6-cr order from Heinz
Tata Cummins to begin manufacturing ISB engine — Cummins, Tata Motors sign pact
Radisson Hotels ties up with Sahil Spa & Resorts
Dr Reddy's ties up with UK's Argenta Discovery
DLF sets up joint venture co with Laing O'Rourke
BPCL mulls early IPO to part-finance Bina refinery
Uma Precision gets $1.6 m from H&M Global
Pudumjee to launch personal hygiene products under Greenlime brand
Tata Motors sees big market for pick-ups
Tata Motors vehicle sales up 19.6% in Jan
TVS Motor records 25 pc growth in motorcycles sales
Aditya Birla group's cement output up



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line